XML 62 R3.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
CURRENT ASSETS:    
Cash and Cash Equivalents $ 5,427,830 $ 118,262
Short-term loans receivable 3,789,900 513,356
Accounts receivable, net of allowance 324,413 36
Non-trade receivables 171,892 1,848,740
Prepaid expenses and other receivable 7,903,035 360,518
Current assets, discontinued operations 269,067
Total current assets 17,617,070 3,109,979
PROPERTY PLANT AND EQUIPMENT, NET 629,185 253,090
OPERATING LEASE RIGHT-OF-USE ASSET 1,918,966 2,212,754
OTHER ASSETS 379,735 502,478
Total Assets 20,544,956 6,078,301
CURRENT LIABILITIES:    
Short-term loans payable 1,589,887 722,797
Short-term loans payable from related parties 259,593
Non-trade accounts payable 2,312,669 1,840,269
Bonds with warrants, net 3,489,995
Accrued expenses and other current liabilities 83,940 65,678
Current liabilities, discontinued operations   979,623
Total current liabilities 7,476,491 3,867,960
BONDS WITH WARRANTS, NET 3,550,856
Total Liabilities 7,476,491 7,418,816
Commitments and contingencies (Note 16)
STOCKHOLDER’SDEFICIT:    
Common Stock, $0.001 par value Authorized 110,000,000 (common:100,000,000, preferred:10,000,000) shares; Issued and outstanding 52,808,589 common shares and 45,416,942 common shares as of December 31, 2023 and December 31, 2022 [1] 52,809 45,417
Additional paid-in capital [1] 51,415,476 27,578,666
Accumulated deficit (38,893,762) (29,607,852)
Accumulated other comprehensive income 493,942 879,420
Equity(Deficit) attributable to equity holder of the Company 13,068,465 (1,104,349)
Non-controlling interests (236,166)
Total Stockholders’ Equity(Deficit) 13,068,465 (1,340,515)
Total Liabilities and Stockholders’ Deficit $ 20,544,956 $ 6,078,301
[1] Retrospectively restated for effect of Change In Capital Structure